Aurora Biolabs
Private Company
Funding information not available
Overview
Aurora Biolabs operates as a premier manufacturer and service provider in the life sciences research tools sector, focusing on enabling drug discovery through reliable, ISO 17025-certified reagents and assays. As a subsidiary of Structure Based Design, Inc. (SBD), it leverages decades of scientific expertise to offer assay development, protein expression, and a 145K-compound library screening service. The company is strategically positioned as a direct US manufacturer, ensuring quality control and cost-effective solutions for academic, biotech, and pharmaceutical research clients.
Technology Platform
Specializes in the production of high-purity recombinant drug target proteins and the development of precise, homogeneous TR-FRET (Time-Resolved Fluorescence Resonance Energy Transfer) fluorescence assays for high-throughput inhibitor screening and drug discovery optimization.
Opportunities
Risk Factors
Competitive Landscape
Aurora Biolabs competes with large reagent suppliers (Thermo Fisher, Merck) and specialized assay providers (BPS Bioscience, Revvity). Its differentiation stems from deep expertise in challenging targets like KRAS, direct US-based manufacturing ensuring quality and supply chain control, and an integrated model combining products with high-end discovery services linked to structural biology expertise via its parent company SBD.